GT200300286A - Derivados biciclicos para el tratamiento del crecimiento celular anormal - Google Patents
Derivados biciclicos para el tratamiento del crecimiento celular anormalInfo
- Publication number
- GT200300286A GT200300286A GT200300286A GT200300286A GT200300286A GT 200300286 A GT200300286 A GT 200300286A GT 200300286 A GT200300286 A GT 200300286A GT 200300286 A GT200300286 A GT 200300286A GT 200300286 A GT200300286 A GT 200300286A
- Authority
- GT
- Guatemala
- Prior art keywords
- treatment
- cellular growth
- abnormal cellular
- bicycle derivatives
- bicycle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE AL COMPUESTO DE FORMULA GENERAL I EN LA QUE R1,R2,R3,R5, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON DE UTILIDAD EN EL TRATAMIENTO DEL CRECIMIENTO CELULAR ANORMAL POR LO QUE VA A INFLUIR CONTRA LOS TRASTORNOS PROLIFERATIVOS TALES COMO EL CANCER.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43448602P | 2002-12-18 | 2002-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200300286A true GT200300286A (es) | 2004-08-13 |
Family
ID=32595280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200300286A GT200300286A (es) | 2002-12-18 | 2003-12-16 | Derivados biciclicos para el tratamiento del crecimiento celular anormal |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040254204A1 (es) |
EP (1) | EP1575592A1 (es) |
JP (1) | JP2006513179A (es) |
KR (1) | KR20050085749A (es) |
CN (1) | CN1729001A (es) |
AR (1) | AR042480A1 (es) |
AU (1) | AU2003303045A1 (es) |
BR (1) | BR0317433A (es) |
CA (1) | CA2510323A1 (es) |
GT (1) | GT200300286A (es) |
MX (1) | MXPA05006335A (es) |
NL (1) | NL1025044C2 (es) |
NO (1) | NO20053483L (es) |
PA (1) | PA8592801A1 (es) |
PE (1) | PE20040905A1 (es) |
PL (1) | PL377686A1 (es) |
RU (1) | RU2005119172A (es) |
TW (1) | TW200424190A (es) |
WO (1) | WO2004054585A1 (es) |
ZA (1) | ZA200504147B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2280003B1 (en) | 2002-07-15 | 2014-04-02 | Symphony Evolution, Inc. | Process for preparing receptor-type kinase modulators |
KR20080014144A (ko) * | 2003-08-18 | 2008-02-13 | 화이자 프로덕츠 인크. | erbB2 항암제에 대한 투약 스케쥴 |
SI2392564T1 (sl) | 2003-09-26 | 2014-02-28 | Exelixis, Inc. | c-Met modulatorji in postopki uporabe |
WO2006129168A2 (en) * | 2005-06-03 | 2006-12-07 | Pfizer Products Inc. | Bicyclic derivatives for the treatment of abnormal cell growth |
WO2008057280A1 (en) | 2006-10-27 | 2008-05-15 | Amgen Inc. | Multi-cyclic compounds and methods of use |
CA2995880C (en) | 2009-01-16 | 2021-01-05 | Exelixis, Inc. | Processes for preparing n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
HUE045810T2 (hu) | 2010-09-27 | 2020-01-28 | Exelixis Inc | MET és VEGF kettõs inhibitorai kasztrációrezisztens prosztatarák és oszteoblasztos csontáttétek kezelésére |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0711783A1 (en) * | 1994-11-08 | 1996-05-15 | Glaxo, S.A. | Antifungal Sordarin derivatives |
UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
ES2334879T3 (es) * | 1999-09-21 | 2010-03-17 | Astrazeneca Ab | Derivados de quinazolina y su uso como productos farmaceuticos. |
BRPI0017067B8 (pt) * | 2000-01-18 | 2021-05-25 | Beyondspring Pharmaceuticals Inc | inibidor de divisão de célula, desidrogenase, método para a produção de um inibidor de divisão de célula e composto |
DZ3407A1 (es) * | 2000-06-22 | 2001-12-27 | Pfizer Prod Inc | |
CN1639149A (zh) * | 2001-11-30 | 2005-07-13 | 辉瑞产品公司 | 制备用于治疗异常细胞生长的取代的双环衍生物的方法 |
HUP0402662A2 (hu) * | 2001-12-12 | 2005-05-30 | Pfizer Products Inc. | Az E-2-metoxi-N-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi)fenilamino]kinazolin-6-il}-allil)acetamid sói, előállításuk és rák elleni alkalmazásuk |
BR0214499A (pt) * | 2001-12-12 | 2005-05-10 | Pfizer Prod Inc | Derivados de quinazolina para o tratamento do crescimento anormal das células |
-
2003
- 2003-12-08 PL PL377686A patent/PL377686A1/pl not_active Application Discontinuation
- 2003-12-08 RU RU2005119172/04A patent/RU2005119172A/ru not_active Application Discontinuation
- 2003-12-08 EP EP03813249A patent/EP1575592A1/en not_active Withdrawn
- 2003-12-08 CA CA002510323A patent/CA2510323A1/en not_active Abandoned
- 2003-12-08 WO PCT/IB2003/005826 patent/WO2004054585A1/en not_active Application Discontinuation
- 2003-12-08 BR BR0317433-6A patent/BR0317433A/pt not_active IP Right Cessation
- 2003-12-08 AU AU2003303045A patent/AU2003303045A1/en not_active Abandoned
- 2003-12-08 MX MXPA05006335A patent/MXPA05006335A/es unknown
- 2003-12-08 CN CNA2003801069555A patent/CN1729001A/zh active Pending
- 2003-12-08 JP JP2004560067A patent/JP2006513179A/ja active Pending
- 2003-12-08 KR KR1020057011285A patent/KR20050085749A/ko not_active Application Discontinuation
- 2003-12-10 PE PE2003001246A patent/PE20040905A1/es not_active Application Discontinuation
- 2003-12-16 US US10/737,691 patent/US20040254204A1/en not_active Abandoned
- 2003-12-16 GT GT200300286A patent/GT200300286A/es unknown
- 2003-12-16 AR ARP030104645A patent/AR042480A1/es unknown
- 2003-12-17 TW TW092135744A patent/TW200424190A/zh unknown
- 2003-12-17 PA PA20038592801A patent/PA8592801A1/es unknown
- 2003-12-17 NL NL1025044A patent/NL1025044C2/nl not_active IP Right Cessation
-
2005
- 2005-05-23 ZA ZA200504147A patent/ZA200504147B/en unknown
- 2005-07-18 NO NO20053483A patent/NO20053483L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2005119172A (ru) | 2006-01-20 |
KR20050085749A (ko) | 2005-08-29 |
CN1729001A (zh) | 2006-02-01 |
AU2003303045A1 (en) | 2004-07-09 |
PA8592801A1 (es) | 2004-07-26 |
NO20053483L (no) | 2005-09-19 |
MXPA05006335A (es) | 2005-08-26 |
WO2004054585A1 (en) | 2004-07-01 |
BR0317433A (pt) | 2005-11-16 |
CA2510323A1 (en) | 2004-07-01 |
PL377686A1 (pl) | 2006-02-06 |
ZA200504147B (en) | 2006-07-26 |
NO20053483D0 (no) | 2005-07-18 |
US20040254204A1 (en) | 2004-12-16 |
PE20040905A1 (es) | 2005-01-18 |
AR042480A1 (es) | 2005-06-22 |
EP1575592A1 (en) | 2005-09-21 |
NL1025044A1 (nl) | 2004-06-21 |
NL1025044C2 (nl) | 2005-02-15 |
TW200424190A (en) | 2004-11-16 |
JP2006513179A (ja) | 2006-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200300296A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
GT200500242A (es) | Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas | |
GT200500103A (es) | 4-fenilamino-quinazolin-6-il-amidas | |
GT200600024A (es) | Derivados de triazol sustituidos como antagonistas de oxitocina | |
ECSP066447A (es) | Derivados de isoquinolina 1,4-disustituida como inhibidores raf-quinasa útiles para el tratamiento de enfermedades proliferativas | |
UY29636A1 (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
GT200500097A (es) | Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central | |
GT200300177A (es) | Terapia de combinacion para enfermedades hiperproliferativas | |
GT200300286A (es) | Derivados biciclicos para el tratamiento del crecimiento celular anormal | |
GT200300289A (es) | Derivados de pirrolopirimidina | |
CU20110052A7 (es) | Compuestos orgánicos | |
GT200700062A (es) | Derivados de amina utiles como agentes anticancerigenos | |
ECSP088536A (es) | DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR | |
GT200600430A (es) | Compuestos de carboxiamina y metodos de uso de los mismos | |
GT200500157A (es) | Difenilimidazopirimidina e imidazol aminas como inhibidores de beta-secretasa | |
GT200600217A (es) | Proceso para la sintesis de compuestos organicos | |
CU20120071A7 (es) | DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA | |
GT200700039A (es) | Derivados de triazolopirazina | |
GT200400274A (es) | Nuevos derivados de quinolina | |
UY29668A1 (es) | Nuevos derivados de heptaazafenaleno, procedimientos para su obtencinn, ase como utilizacinn de estos como agentes protectores contra la radicacinn uv.- | |
ECSP11010804A (es) | Compuestos orgánicos | |
CO6300898A2 (es) | Sales y polimorfos de 9-(2,2-dimetil-propil-aminometil)-minociclina | |
DE602006010433D1 (de) | Für die behandlung von obesitas geeignete tricyclische amidderivate | |
DOP2006000069A (es) | Nuevos compuestos farmaceuticos. | |
GT200600326A (es) | Diazepinoquinolinas, sintesis de las mismas e intermediarios de las mismas |